Edition:
United Kingdom

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

0.97USD
18 Jan 2019
Change (% chg)

$-0.01 (-0.73%)
Prev Close
$0.98
Open
$1.00
Day's High
$1.00
Day's Low
$0.96
Volume
10,646
Avg. Vol
302,283
52-wk High
$5.86
52-wk Low
$0.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 21 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-19 1 146.90 146.90 146.90 189.20
Earnings (per share)
Year Ending Dec-19 1 -3.64 -3.64 -3.64 -0.43

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 34.20 30.33 3.87 11.30
Quarter Ending Jun-18 35.00 31.90 3.10 8.85
Quarter Ending Mar-18 35.10 27.48 7.62 21.70
Quarter Ending Dec-17 32.78 38.91 6.13 18.70
Quarter Ending Sep-17 35.95 28.67 7.28 20.25
Earnings (per share)
Quarter Ending Sep-18 -1.49 -1.32 0.17 -11.41
Quarter Ending Jun-18 -0.79 -1.67 0.88 -112.74
Quarter Ending Mar-18 -0.34 -1.76 1.42 -417.65
Quarter Ending Dec-17 -0.94 -1.32 0.39 -41.18
Quarter Ending Sep-17 -0.30 -0.89 0.59 -196.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-19 146.90 146.90 146.90 146.90 189.20
Earnings (per share)
Year Ending Dec-19 -3.64 -3.64 -3.64 -3.64 -0.43

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-19 0 0 0 0
Earnings
Year Ending Dec-19 0 0 0 0